264 related articles for article (PubMed ID: 8169847)
1. Vasodilator-derived nitric oxide inhibits fetal calf serum- and angiotensin-II-induced growth of renal arteriolar smooth muscle cells.
Dubey RK
J Pharmacol Exp Ther; 1994 Apr; 269(1):402-8. PubMed ID: 8169847
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of nitrovasodilators and cyclic GMP on ET-1-activated Ca(2+)-permeable nonselective cation channel in rat aortic smooth muscle cells.
Minowa T; Miwa S; Kobayashi S; Enoki T; Zhang XF; Komuro T; Iwamuro Y; Masaki T
Br J Pharmacol; 1997 Apr; 120(8):1536-44. PubMed ID: 9113376
[TBL] [Abstract][Full Text] [Related]
3. Control of vascular smooth muscle cell growth in fowl.
Shimada T; Fabian M; Yan HQ; Nishimura H
Gen Comp Endocrinol; 1998 Oct; 112(1):115-28. PubMed ID: 9748410
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of SNAP potentiating antiproliferative effect of calcitonin gene-related peptide in cultured vascular smooth muscle cells.
Wang X; Wang W; Li Y; Bai Y; Fiscus RR
J Mol Cell Cardiol; 1999 Sep; 31(9):1599-606. PubMed ID: 10471344
[TBL] [Abstract][Full Text] [Related]
5. Regulation of endothelin receptors by nitric oxide in cultured rat vascular smooth muscle cells.
Redmond EM; Cahill PA; Hodges R; Zhang S; Sitzmann JV
J Cell Physiol; 1996 Mar; 166(3):469-79. PubMed ID: 8600150
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols.
Kowaluk EA; Fung HL
J Pharmacol Exp Ther; 1990 Dec; 255(3):1256-64. PubMed ID: 2175799
[TBL] [Abstract][Full Text] [Related]
7. The effect of nitric oxide on fetal pulmonary artery smooth muscle growth.
Thomae KR; Nakayama DK; Billiar TR; Simmons RL; Pitt BR; Davies P
J Surg Res; 1995 Sep; 59(3):337-43. PubMed ID: 7643591
[TBL] [Abstract][Full Text] [Related]
8. Relationship between cyclic guanosine monophosphate accumulation and relaxation of canine trachealis induced by nitrovasodilators.
Zhou HL; Torphy TJ
J Pharmacol Exp Ther; 1991 Sep; 258(3):972-8. PubMed ID: 1679854
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.
Garg UC; Hassid A
J Clin Invest; 1989 May; 83(5):1774-7. PubMed ID: 2540223
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide donor SNAP induces apoptosis in smooth muscle cells through cGMP-independent mechanism.
Nishio E; Fukushima K; Shiozaki M; Watanabe Y
Biochem Biophys Res Commun; 1996 Apr; 221(1):163-8. PubMed ID: 8660329
[TBL] [Abstract][Full Text] [Related]
11. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells.
Aizawa T; Wei H; Miano JM; Abe J; Berk BC; Yan C
Circ Res; 2003 Sep; 93(5):406-13. PubMed ID: 12919948
[TBL] [Abstract][Full Text] [Related]
12. Culture of rat mesenteric arteriolar smooth muscle cells: effects of platelet-derived growth factor, angiotensin, and nitric oxide on growth.
Dubey RK; Overbeck HW
Cell Tissue Res; 1994 Jan; 275(1):133-41. PubMed ID: 8118839
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives on vascular smooth muscle cell mitogenesis and proliferation in vitro.
Lähteenmäki T; Sievi E; Vapaatalo H
Br J Pharmacol; 1998 Sep; 125(2):402-8. PubMed ID: 9786515
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
Ebihara Y; Karmazyn M
Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
[TBL] [Abstract][Full Text] [Related]
15. The role of cyclic guanylate monophosphate in nitric oxide-induced injury to rat small intestinal epithelial cells.
Tepperman BL; Abrahamson TD; Soper BD
J Pharmacol Exp Ther; 1998 Mar; 284(3):929-33. PubMed ID: 9495851
[TBL] [Abstract][Full Text] [Related]
16. Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion.
Marczin N; Ryan US; Catravas JD
J Pharmacol Exp Ther; 1992 Oct; 263(1):170-9. PubMed ID: 1328604
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide modulates Gi-protein expression and adenylyl cyclase signaling in vascular smooth muscle cells.
Bassil M; Anand-Srivastava MB
Free Radic Biol Med; 2006 Oct; 41(7):1162-73. PubMed ID: 16962941
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide inhibits migration of cultured endothelial cells.
Lau YT; Ma WC
Biochem Biophys Res Commun; 1996 Apr; 221(3):670-4. PubMed ID: 8630019
[TBL] [Abstract][Full Text] [Related]
19. L-Citrulline, the by-product of nitric oxide synthesis, decreases vascular smooth muscle cell proliferation.
Ruiz E; Del Rio M; Somoza B; Ganado P; Sanz M; Tejerina T
J Pharmacol Exp Ther; 1999 Jul; 290(1):310-3. PubMed ID: 10381792
[TBL] [Abstract][Full Text] [Related]
20. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]